AKT1 and cancer: The downregulation of the PI3K/AKT pathway by fucoidan contributed, in part, to a reduced expression of CDK-4, CDK-6, cyclin-E, and cyclin-D1, consequently halting cancer cell growth while inducing the apoptosis of the cancer cells [67].